SARA NIKNAM: Open Payments
NPI 1790292712 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,134 in 46 payments from 11 companies in 2025. Trend: 2023 $562 · 2024 $467 · 2025 $1,134
Food & beverage: $1,134
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 14 | $220 |
| ABBVIE INC. | 10 | $197 |
| PFIZER INC. | 8 | $157 |
| SI-BONE, INC. | 1 | $137 |
| Electronic Waveform Lab, Inc. | 1 | $118 |
| Curonix LLC | 3 | $101 |
| Merz Pharmaceuticals, LLC | 2 | $67 |
| SCILEX PHARMACEUTICALS INC. | 3 | $49 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $44 |
| Abbott Laboratories | 1 | $30 |
Products named: XTAMPZA, NURTEC ODT, QULIPTA, PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A, Xeomin, UBRELVY, ZTLido, RELISTOR.
Industry payments across CA — which companies pay providers there.
